Identification of Polymorphic Forms of Active Pharmaceutical Ingredient in Low-Concentration Dry Powder Formulations by Synchrotron X-Ray Powder Diffraction
Crossref DOI link: https://doi.org/10.1007/s40268-017-0196-6
Published Online: 2017-09-13
Published Print: 2017-09
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Egusa, Kenji
Okazaki, Fumiaki
Schiewe, Joerg
Werthmann, Ulrike
Wolkenhauer, Markus
License valid from 2017-09-01